The “Global Vasectomy Market Size Is Expected to Reach USD 24.0 Billion at a CAGR of ~ 7.1 % During the By the End of Forecast Period 2017-2023”.
Vasectomy is male sterilization surgery, which involves severing the male vas deferens to prevent sperm from entering into the urethra. It is a permanent procedure of preventing fertilization as reversal is costly and often does not restore the male's fertility.
The advantages of minimal invasive surgical procedures such as low hospital stay, low trauma and surgical footprint, less pain has resulted in greater demand for minimal invasive procedures and thus, greater acceptance.
Vasectomy Market Segmental Analysis:
The global vasectomy market has been segmented on the basis of type, drug, patient, and end user.
Based on the type, the market has been segmented as conventional vasectomy, no-scalpel vasectomy, and minimally invasive vasectomy.
Based on the drug, the market has been segmented as anesthetics, pain killers, antibiotics, and others.
Based on the patient, the market has been segmented as humans, and animals.
Based on the end user, the market has been segmented as hospitals and clinics, research and academics, and others.
Key Players in the Global Vasectomy Market
Some of the key players profiled in the report are:
- Pfizer Inc.
- Abbott
- GlaxoSmithKline plc
- Sanofi S.A.
- Novartis AG
- Bayer AG
- Bristol Myers Squibb Company
- Eli Lilly and Company Inc.
- Accurate Surgical & Scientific Instruments Corporation
- Sklar Surgical Instruments
- Advanced Meditech International and others.
Brows Complete Detailed Research Report at https://www.marketresearchfuture.com/reports/vasectomy-market-4703
Vasectomy Market Regional Analysis:
The Americas account for a major share of the market owing to high expenditure on the health care, especially, of the U.S. and Canada. Additionally, the greater number of vasectomies due to greater male-female equality in the U.S. and Canada drives the vasectomy market. Moreover, the large share of surgeries in the returns of hospitals favors the market. Canada has a higher rate of people undergoing vasectomies than the U.S.
Europe is the second largest market in the world due to growing the pharmaceutical and industrial base. The European market growth is led by countries such as Germany and France. Germany is expected to be the fastest growing market over the assessment period. Belgium, Denmark, and Switzerland have a higher rate of people undergoing vasectomies than other nations of Europe.
Asia Pacific region is expected to proliferate; China and India are likely to lead this market due to the fast-growing healthcare sector and large unmet needs over the forecast period. India was the first nation in the world to include population control as a national program way back in 1952. South East Asian countries such as China, India, and Malaysia are projected to contribute highly to the market growth.
Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. Other Middle East nations to watch out for are Kuwait, Jordan, Egypt, and Iran. The African region is expected to witness a poor growth owing to weak economic and political conditions, and inadequate healthcare development. Botswana and South Africa are expected to be the future markets with approximately 1% rate of people undergoing vasectomies.
Contact About Market Research Future:
Comments
Post a Comment